Single Family Office

Updated:

Veritas Genetics

Veritas Genetics is a single-family office in Danvers, MA, managing wealth from the genetics testing sector with focus on private healthcare investments.

Veritas Genetics

Veritas Genetics Inc. is a single-family office based in Danvers, Massachusetts. The firm was established to manage and grow the wealth derived from the founders' involvement in the genomics and diagnostic testing industry. The office structure is lean, reflecting a preference for direct oversight of deployed capital. Strategy centers on direct private investments, with a focus on healthcare services, biotechnology, and health technology sectors. The firm targets early-to-growth-stage companies where it can provide operational or strategic support. Deal sourcing is proprietary, drawing on the principals' network in the life sciences and diagnostics ecosystem. Confirmed portfolio companies are not publicly listed, but the firm is known to back ventures where genomic data, precision medicine, or clinical lab services are core. Team size and total deployment are not disclosed. The firm operates out of a single Danvers office. There are no public records of philanthropic foundations or adjacent vehicles. No named operational events from the last 24 months are available in public sources. The structural differentiator is the family office's direct sourcing model tied to the principals' deep domain expertise in genetics, which provides a lens for evaluating healthcare and life sciences deals that generalist investors may overlook. Governance is likely concentrated among the founding family, with limited external advisory.

General information

Firm type

Single Family Office

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Danvers

Corporate office

Danvers, MA, United States

Frequently asked questions

Who runs investment decisions at Veritas Genetics?

The investment decisions are run by the founding family principals, whose names are not publicly disclosed. The lean structure suggests concentrated authority among the core family members, with no external CIO or investment committee named in public records.

How does Veritas Genetics source proprietary deal flow?

The firm sources deal flow primarily through the principals' network in the genetic testing and diagnostic industry, leveraging relationships built over decades in the genomics sector. This network provides access to private companies where the office can invest directly, often ahead of institutional investors.

Is Veritas Genetics structured as a single family office or does it operate more like a venture firm?

Veritas Genetics is structured as a single-family office and does not operate as a traditional venture firm. It does not raise external capital or manage funds for third-party LPs, focusing instead on deploying the family's own wealth through direct investments.

Does Veritas Genetics participate in fund commitments or only direct deals?

Based on public information, Veritas Genetics focuses primarily on direct private investments rather than committing capital to external pooled funds. The firm prefers to maintain control over its investment decisions and avoid the fee structures of fund commitments.

What investment stages does Veritas Genetics typically target?

The firm targets early-to-growth-stage private companies, particularly in healthcare, biotech, and health technology. It shows a preference for ventures where the principals' operational or strategic expertise can add value, rather than passive later-stage or public market allocations.

Which sectors does Veritas Genetics explicitly avoid?

There is no public disclosure of sectors that Veritas Genetics explicitly avoids. However, given the firm's domain expertise, it likely stays within healthcare- and technology-adjacent industries and may avoid extractive or commodity-based investments.

Where does the underlying wealth come from?

The underlying wealth originates from the genetic testing and diagnostic health technology sector. The principals were involved in the genomics and clinical lab services industry, which provided the capital base for the family office's current investment activities.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo